Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Faster, Cleaner, Better.

Meridian Bioscience (VIVO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 09/30

(Values in U.S. thousands)

	09-2007	09-2006	09-2005	09-2004	09-2003
Assets
Current Assets
Cash & Cash Equivalents	49,400	36,348	33,085	1,983	2,083
Marketable Securities	N/A	4,000	N/A	N/A	N/A
Receivables	22,651	19,645	17,366	17,857	14,894
Inventories	18,171	16,989	16,785	14,107	14,066
Income taxes - deferred	1,376	1,651	1,258	495	216
TOTAL	$93,745	$80,742	$70,160	$36,111	$32,561

Non-Current Assets
PPE Net	18,311	17,807	17,460	17,342	17,550
Intangibles	19,421	20,680	22,028	14,698	15,198
Other Non-Current Assets	1,221	1,299	921	1,171	1,111
TOTAL	$38,953	$39,786	$40,409	$33,211	$33,859

Total Assets	$132,698	$120,528	$110,569	$69,322	$66,420

Liabilities
Current Liabilities
Short Term Debt	N/A	N/A	556	696	879
Accounts payable and accrued liabilities	4,704	3,671	2,949	2,631	2,271
Accrued Expenses	7,541	7,896	7,707	6,311	4,534
Other current liabilities	152	937	1,313	678	463
TOTAL	$17,067	$20,617	$19,791	$16,650	$15,330

Non-Current Liabilities
Long Term Debt	N/A	N/A	233	1,093	1,505
Other Non-Current Liabilities	0	1,803	2,451	16,000	20,000
TOTAL	$2,683	$5,561	$7,010	$19,740	$23,606

Total Liabilities	$19,750	$26,178	$26,801	$36,390	$38,936

Shareholders' Equity
Shares Outstanding, K	39,878	39,238	39,090	33,884	33,359
Common Shares	N/A	N/A	N/A	N/A	2,535
Retained earnings	30,375	19,490	12,687	7,322	3,930
Other shareholders' equity	364	-90	-487	-326	-622
TOTAL	$112,948	$94,350	$83,768	$32,932	$27,484

Total Liabilities And Equity	$132,698	$120,528	$110,569	$69,322	$66,420